Publication:
Far from luck's way: a concurrence of Kaposi sarcoma and cutaneous angiosarcoma in the setting of chronic lymphocytic leukemia

dc.contributor.kuauthorSezgin, Billur
dc.contributor.kuauthorYiğit, Yeşim Esen
dc.contributor.kuauthorTatar, Sedat
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.kuauthorDurankuş, Nilüfer Kılıç
dc.contributor.kuauthorKulaç, İbrahim
dc.contributor.kuauthorAtasoy, Pınar
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokid133762
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid202015
dc.contributor.yokidN/A
dc.contributor.yokid170305
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T12:44:17Z
dc.date.issued2020
dc.description.abstractKaposi sarcoma and cutaneous angiosarcoma are rare forms of skin malignancies that are vascular in nature and are frequently encountered in the immunosuppressed population. Although synchronous angiosarcoma and Kaposi sarcoma have been documented, to our knowledge, the coexistence of these vascular malignancies with underlying chronic lymphocytic leukemia has not been previously reported. A 51-year-old male patient with chronic lymphocytic leukemia presented with Kaposi sarcoma located on his left ankle. Shortly after, the patient presented with de novo lesions located on the plantar region of the right foot, reported as angiosarcoma. Following a multidisciplinary decision, treatment with adjuvant chemotherapy consisting of paclitaxel and carboplatin with consolidation radiotherapy was planned. The patient's Kaposi sarcoma has remained unchanged throughout this period.In such cases, the treatment is advised to be planned around the more aggressive malignancy. These patients should also be followed-up by dermatology due to the higher risk of secondary cutaneous malignancies.
dc.description.fulltextYES
dc.description.indexedbyScopus
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume16
dc.formatpdf
dc.identifier.doi10.4103/JCAS.JCAS_127_19
dc.identifier.eissn0974-5157
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02575
dc.identifier.issn0974-2077
dc.identifier.linkhttps://doi.org/10.4103/JCAS.JCAS_127_19
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85097285268
dc.identifier.urihttps://hdl.handle.net/20.500.14288/2395
dc.keywordsAngiosarcoma
dc.keywordsChronic lymphocytic leukemia
dc.keywordsCutaneous angiosarcoma
dc.keywordsImmunosuppression
dc.keywordsKaposi sarcoma
dc.languageEnglish
dc.publisherMedknow Publications
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9218
dc.sourceJournal of Cutaneous and Aesthetic Surgery
dc.subjectMedicine
dc.titleFar from luck's way: a concurrence of Kaposi sarcoma and cutaneous angiosarcoma in the setting of chronic lymphocytic leukemia
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-7322-5214
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authorid0000-0002-1273-1674
local.contributor.authoridN/A
local.contributor.authorid0000-0003-2003-7567
local.contributor.authoridN/A
local.contributor.kuauthorSezgin, Billur
local.contributor.kuauthorYiğit, Yeşim Esen
local.contributor.kuauthorTatar, Sedat
local.contributor.kuauthorSelçukbiricik, Fatih
local.contributor.kuauthorDurankuş, Nilüfer Kılıç
local.contributor.kuauthorKulaç, İbrahim
local.contributor.kuauthorAtasoy, Pınar

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9218.pdf
Size:
3.51 MB
Format:
Adobe Portable Document Format